Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPIA | P62937 | 6/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 2/20 | 0.35 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.35 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.35 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.35 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL7516104 | 0.78 | CHRNB2 (0.42) | PPIACHRNB2CHRNA4KDM1AKDM1B | |
| SCHEMBL28865931 | 0.78 | PPIA (0.46) | PPIACHRNB2CHRNA4TNKS2PDK2 | |
| SCHEMBL18242520 | 0.78 | PPIA (0.49) | PPIACHRNB2CHRNA4TNKS2KDM1A | |
| SCHEMBL29797969 | 0.77 | GPR3 (0.46) | HTR2AGPR3CYP19A1 | |
| SCHEMBL4359049 | 0.77 | GPR3 (0.46) | HTR2AGPR3CYP19A1 | |
| Hydrochloric Acid SCHEMBL7606641 | 0.76 | CHRNB2 (0.41) | PPIACHRNB2CHRNA4KDM1AKDM1B | |
| SCHEMBL4011644 | 0.75 | HTR7 (0.30) | HTR2AGPR3 | |
| SCHEMBL28773457 | 0.75 | IDO1 (0.41) | PPIAHTR2ACHRNB2CHRNA4KDM1A | |
| SCHEMBL28619081 | 0.73 | CA1 (0.40) | PPIATNKS2SMARCA2SMARCA4PBRM1 | |
| SCHEMBL7111303 | 0.73 | MEN1 (0.39) | PPIAHTR2AGPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250120252-A1 | MATERIALS FOR FORMING A NUCLEATION-INHIBITING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2025-04-10 | — | — | US | claimed |
| US-12178064-B2 | Materials for forming a nucleation-inhibiting coating and devices incorporating same | OTI LUMIONICS INC. (CA) | 2024-12-24 | — | — | US | claimed |
| US-12069939-B2 | Method for patterning a coating on a surface and device including a patterned coating | OTI LUMIONICS INC. (CA) | 2024-08-20 | — | — | US | claimed |
| US-20230363196-A1 | MATERIALS FOR FORMING A NUCLEATION-INHIBITING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2023-11-09 | — | — | US | claimed |
| CN-116583131-A | Method for patterning a surface coating and apparatus comprising a patterned coating | OTI照明公司 | 2023-08-11 | — | — | CN | claimed |
| US-20230165124-A1 | METHOD FOR PATTERNING A COATING ON A SURFACE AND DEVICE INCLUDING A PATTERNED COATING | OTI LUMIONICS INC. (CA) | 2023-05-25 | — | — | US | claimed |
| US-11581487-B2 | Patterned conductive coating for surface of an opto-electronic device | OTI LUMIONICS INC. (CA) | 2023-02-14 | — | — | US | claimed |
| US-12590244-B2 | Method for patterning a coating on a surface and device including a patterned coating | OTI LUMIONICS INC. (CA) | 2026-03-31 | — | — | US | disclosed |
| US-20250120252-A1 | MATERIALS FOR FORMING A NUCLEATION-INHIBITING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2025-04-10 | — | — | US | disclosed |
| US-20250024700-A1 | DEVICE INCLUDING A CONDUCTIVE COATING DISPOSED OVER EMISSIVE REGIONS AND METHOD THEREFOR | OTI Lumonics Inc. (CA) | 2025-01-16 | — | — | US | disclosed |
| US-12178064-B2 | Materials for forming a nucleation-inhibiting coating and devices incorporating same | OTI LUMIONICS INC. (CA) | 2024-12-24 | — | — | US | disclosed |
| US-12150374-B2 | Method for patterning a coating on a surface and device including a patterned coating | OTI LUMIONICS INC. (CA) | 2024-11-19 | — | — | US | disclosed |
| US-20240381754-A1 | METHOD FOR PATTERNING A COATING ON A SURFACE AND DEVICE INCLUDING A PATTERNED COATING | OTI LUMIONICS INC. (CA) | 2024-11-14 | — | — | US | disclosed |
| US-4540700-A | Treatment of diabetic complications with certain spiro-imidazolidine-diones | ALCON LABORATORIES, INC. (US) | 1985-09-10 | — | — | US | disclosed |
| US-4438272-A | COMPLICATIONS OF DIABETES | ALCON LABORATORIES, INC. (US) | 1984-03-20 | — | — | US | disclosed |
| US-4436745-A | TETRACYCLIC SPIROHYDANTOINS | ALCON LABORATORIES, INC. (US) | 1984-03-13 | — | — | US | disclosed |
| WO-1983003543-A1 | METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS | ALCON LAB INC (US) | 1983-10-27 | — | — | WO | disclosed |
| WO-1983003543-A1 | METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS | ALCON LAB INC (US) | 1983-10-27 | — | — | WO | disclosed |
| EP-0092385-A2 | Hydantoin derivatives for use in inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluoren compounds | ALCON LABORATORIES, INC. (US) | 1983-10-26 | — | — | EP | disclosed |
| EP-0092385-A2 | Hydantoin derivatives for use in inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluoren compounds | ALCON LABORATORIES, INC. (US) | 1983-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590244-B2 | Method for patterning a coating on a surface and device including a patterned coating | FLNB, FZD7, ITGB6 | PPIA 1740/4885HTR2A 2156/4885CHRNB2 685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.